US OptionsDetailed Quotes
AVXL241220P2000
- 0.00
- 0.000.00%
15min DelayClose Dec 23 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest2.00Strike Price0.00Turnover0.00%IV82.11%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Anavex Life Sciences Stock Discussion
Sign in to post a comment
1
5
$Anavex Life Sciences (AVXL.US)$ Blarcamesine Receives EMA Filing Acceptance for Treatment of Alzheimer’s Disease
Hi mooers! ![]()
Need a quick update on this week's events? Check out moomoo's fresh earnings & economic calendars to start this week!![]()
For more details, check out the earnings calendar and economic calendar!
This week, various companies including $Anavex Life Sciences (AVXL.US)$ , $Limoneira (LMNR.US)$ and $Venu Holding (VENU.US)$ are releasing their earnings. How will the market react to the companies' results? Let's keep our eyes peeled and see who will shine b...
Need a quick update on this week's events? Check out moomoo's fresh earnings & economic calendars to start this week!
For more details, check out the earnings calendar and economic calendar!
This week, various companies including $Anavex Life Sciences (AVXL.US)$ , $Limoneira (LMNR.US)$ and $Venu Holding (VENU.US)$ are releasing their earnings. How will the market react to the companies' results? Let's keep our eyes peeled and see who will shine b...
13
$Anavex Life Sciences (AVXL.US)$ a Good Company, and def undervalued. They have done so much in the past 6 months. However where they are at, there not making money, just research
1
$Anavex Life Sciences (AVXL.US)$ crossing over mid Bollinger band on day chart , possible to see 9. + soon
$Anavex Life Sciences (AVXL.US)$
$Sunshine Biopharma (SBFM.US)$
$Rumble (RUM.US)$
Got a few superbouncy balls this evening.
making me dizzy 🤣
$Sunshine Biopharma (SBFM.US)$
$Rumble (RUM.US)$
Got a few superbouncy balls this evening.
making me dizzy 🤣
$Anavex Life Sciences (AVXL.US)$
Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference
Anavex Life Sciences (Nasdaq: AVXL) announced it will present new long-term data from the Phase IIb/III ATTENTION-AD Open-Label-Extension (OLE) trial for blarcamesine in early Alzheimer's disease at the J.P. Morgan 2025 Healthcare Conference. The presentation will showcase data from up to 144 weeks of continuous treatm...
Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference
Anavex Life Sciences (Nasdaq: AVXL) announced it will present new long-term data from the Phase IIb/III ATTENTION-AD Open-Label-Extension (OLE) trial for blarcamesine in early Alzheimer's disease at the J.P. Morgan 2025 Healthcare Conference. The presentation will showcase data from up to 144 weeks of continuous treatm...
No comment yet
Jaguar8 : I love this news this morning
Trytosaveabit OP Jaguar8 : 100%! I did as well! And I’m totally ok with it not getting a lot of attention! Hehehe
Jaguar8 Trytosaveabit OP : True. No attention is definitely good because we will have few lurkers around haha
Trytosaveabit OP Jaguar8 : Right! Hehehe
Iwill TradeScared : Looks like forcast trajectory is good almost 400% past 8-9 month being clinical stage and no revenue is only problem for long term investment